VIA EDGAR

Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street N.W.
Washington, D.C. 20549

     RE SurgiCare, Inc.

To Whom It May Concern:

     On behalf of SurgiCare, Inc. we enclose the Form 10Q for the period ending
3/31/2001. If you have any questions please feel free to call.  Thank you.

                                             Sincerely,

                                             /s/ Charles S. Cohen
                                                 Charles S. Cohen
                                                 Chief Operating Officer



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                   FORM 10-QSB



[X]  Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act
     of 1934 For the quarterly period ended March 31, 2001

[    ] Transition report under Section 13 or 15(d) of the Securities Exchange
     Act of 1934 For the transition period from _________ to ________




                                 SURGICARE, INC.
                 (NAME OF SMALL BUSINESS ISSUER IN ITS CHARTER)


          DELAWARE                                        58-1597246
(STATE OR OTHER JURISDICTION OF            (I.R.S. EMPLOYER IDENTIFICATION NO.)
 INCORPORATION OR ORGANIZATION)


  6699 CHIMNEY ROCK, SUITE 105
    HOUSTON, TEXAS(ADDRESS OF                                77081
   PRINCIPAL EXECUTIVE OFFICES)                           (ZIP CODE)

ISSUER'S TELEPHONE NUMBER: (713) 665-1406


Check whether the Registrant: (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

Yes [X]  No [ ]

As of May 3, 2001, 13,954,320 shares of Common Stock, $0.005 par value per
share, were outstanding.

As of May 3, 2001, 1,500,000 shares of Preferred "Series A" Stock, $0.001 par
value per share, were outstanding.

Transitional Small Business Disclosure Format:  Yes [ ]  No [X]

<PAGE>

PART I
                              FINANCIAL INFORMATION


The information contained herein contains certain forward looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended and
Section 21E of the Securities Exchange Act of 1934, as amended, which are
intended to be covered by the safe harbors created thereby. Investors are
cautioned that all forward looking statements involve risks and uncertainty,
including, without limitation, the ability of SurgiCare to continue its
expansion strategy, changes in federal or state healthcare laws and regulations
or third party payer practices, SurgiCare's historical and current compliance
with existing or future healthcare laws and regulations and third party payer
requirements, changes in costs of supplies, labor and employee benefits, as well
as general market conditions, competition and pricing. Although SurgiCare
believes that the assumptions underlying the forward looking statements
contained herein are reasonable, any of the assumptions could be inaccurate, and
therefore, there can be no assurance that the forward looking statements
included in this Form 10-QSB will prove to be accurate. In view of the
significant uncertainties inherent in the forward looking statements included
herein, the inclusion of such information should not be regarded as a
representation by SurgiCare or any other person that the objectives and plans of
SurgiCare will be achieved. SurgiCare undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions, the occurrence
of unanticipated events or changes to future operating results over time.



ITEM 1.

Financial Statements

The information required hereunder is included in this report as set forth
in the "Index to Financial Statements"

                          INDEX TO FINANCIAL STATEMENTS
                                                                            Page
Consolidated Balance Sheet as of December 31 2000, and
March 31, 2001                                                      3

Consolidated  Income  Statement for the 3 months ending as
of March 31, 2000 and 2001.                                         5

Consolidated Statement of Cash Flows for the 3 months ending
as of March 31, 2000 and 2001.                                      6


<PAGE>



                                 SURGICARE, INC.
<TABLE>

<CAPTION>
                           CONSOLIDATED BALANCE SHEETS


                                                     December 31,     March 31,
                                                        2000            2001
                                                                     (Unaudited)
                            ASSETS
<S>                                                      <C>
Current Assets
     Cash and cash equivalents                       $   21,666   $     129,966
     Accounts receivable (less allowance for
      contractual adjustments and doubtful accounts    3,088,916      4,533,018
      of $3,913,389)
     Shareholder receivabls                              244,500
     Inventory                                           620,150        565,026
     Prepaid expenses                                    120,042        113,910
     Other current Assets                                 27,187        137,048
        Total Current Assets                           4,122,461      5,478,968

Property and Equipment
     Office furniture and equipment                      159,891        159,891
     Medical and surgical equipment                    2,143,490      2,335,648
     Leasehold improvements                              812,064        817,064
     Computer equipment                                   68,628         68,628
     Autos                                                30,142         30,142
     Construction in progress                                               166

                                                       3,214,215      3,411,539

     Less: Accumulated depreciation and                (712,649)       (833,887)
        amortization

        Total Property and Equipment                   2,501,566      2,577,652


Other Assets
     Goodwill                                          7,485,918       7,358,522
     MV Loan Fee                                         157,575         154,190
     Prepaid Consulting Fee                                              245,000
     Investment in San Jacinto                           331,868         350,521




        TOTAL ASSETS                              $   14,599,388      16,164,853




<PAGE>





                                 SURGICARE, INC.

                           CONSOLIDATED BALANCE SHEETS



                         LIABILITIES

Current Liabilities
     Current portion of capital lease             $       79,383          80,899
     Line of Credit                                      353,140         374,941
     Notes Payable                                     1,651,711       1,941,433
     Accounts Payable                                    664,760         922,396
     Accrued Expenses                                    367,201         361,442
     Federal income tax payable                          422,441         542,543
     Deferred federal income tax                         795,000         783,100

        Total Current Liabilities                      4,333,636       5,006,755

Minority Interest in Partnership                         202,600         444,919

Long-Term Liabilities
     Lease Obligations                                    38,383         206,145
     Notes Payable                                     4,556,894       4,625,096
        Total Liabilities                              9,131,513      10,282,915

                SHAREHOLDERS' EQUITY

Preferred Stock, Series A, par value
  $.001, 1,650,000 authorized, 1,400,000 issued            1,450           1,316
   and outstanding at March 31, 2000

Common Stock, par value $.005, 50,000,000 shares
     authorized, 12,654,351 issued and outstanding          69,771          70,446
     at March 31, 2000

Additional Paid-In Capital                             4,710,907       4,991,301

Retained Earnings                                        693,997         838,125

Less:   Treasury stock
        Shareholders receivables                         (8,250)        (19,250)

        Total Shareholders' Equity                     5,467,875       5,881,938

     TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY   $   14,599,388    $ 16,164,853
</TABLE>

<PAGE>




                                 SURGICARE, INC.
<TABLE>
<CAPTION>

                          CONSOLIDATED INCOME STATEMENT
                                   (unaudited)

                                                           FOR THE
                                                      THREE MONTHS ENDING
                                                          March 31,

                                                       2000        2001
<S>                                                <C>          <C>

Revenues, net .................................. $ 1,228,703     $3,168,317

Expenses
Direct Surgical Expenses
      Surgical Costs ...........................     193,208        584,166
      Salaries, wages and benefits .............     108,615        338,544
      Contract services ........................      31,029        126,089
                                                    ----------------------------
              Total Direct Surgical Expenses ...     332,852      1,048,799
 Gen. and Admin. Expenses
      Salaries, Wages and benefits                    46,702        216,253
      Professional fees ........................       6,791        270,591
      Rent .....................................      40,682        112,142
      Management fees ..........................      21,218         18,657
      Depreciation and amortization ............      42,217        252,018
      Consulting fees ..........................                     35,000
      Repairs and maintenance ..................      12,298
      Other operating expenses .................      52,135        149,515
      Taxes ....................................      35,780         32,372
                                                    ---------------------------
          Total Direct Gen. and Admin.  Expenses     266,760      1,086,547
                                                    ---------------------------
          Total Expenses .......................     599,612      2,135,346

Other (Income) Expense
      Gain on sale of property and equipment ...           0            0
      Miscellaneous income .....................           0         57,000
      Equity and Earnings of Limited Partnership                     38,653
      Interest Expense                                             (167,303)
                                                    ----------------------------
          Total Other Income ...................           0       (128,593)

      Minority Interest
        Memorial Village                                            (302,319)

Earnings Before Federal Income Tax Expense .....                     602,509

Federal Income Tax Expense (Benefit)
      Deferred .................................      30,090        (76,745)
      Current ..................................     180,280         311,741
                                                   -----------------------------

Net Earnings .................................  $    418,721         367,063
                                                   =============================


      Pro forma earnings per share - basic and .$      0.02  $         .024
      diluted


</TABLE>


<PAGE>





                                 SURGICARE, INC.
<TABLE>
<CAPTION>

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (unaudited)
                                                           FOR THE
                                                      THREE MONTHS ENDING
                                                            March 31,

<S>                                                   <C>            <C>
                                                      2000           2001
Cash Flows From Operating Activities
     Net earnings                              $     418,721        367,063
     Investment Income                                              (39,644)
     Minority Interest In Partnership                               302,319
     Adjustments to reconcile net earnings to
     net cash provided by operations:

         Depreciation and amortization                42,217        252,019
         Gain on sale of property and                      0             0
         equipment
         Cash consulting Expense                                     35,000
         Deferred federal income tax                  30,090        (11,900)
         Management company termination fee
         (Increase) Decrease in:
         Accounts receivable                        (146,670)    (1,444,102)
         Inventory                                      (176)        55,124
         Prepaid expenses                              3,785          6,132
         Other current assets                           (226)      (109,861)
         State Income Tax Payable                     30,934
         Federal Income Tax                          122,335        120,102
         Increase (Decrease) in:
         Accounts payable                            106,049        257,636
         Accrued expenses                            (21,292)       (5,758)

         Net Cash Provided by Operating              585,769       (215,870)
         Activities

Cash Flows From Investing Activities
     Capital expenditures                           (279,080)      (8,324)
     Collections on shareholder receivable            25,750
     Proceeds from sale of property and
     equipment
     New Shareholder Receivable                     (244,500)
         Acquisition of SurgiCare, Inc.
         Net Cash Used in Investing Activities      (520,330)      (8,324)

Cash Flows From Financing Activities
     Proceeds from notes payable                                  (676,195)
     Borrowings on debt
     Payments on debt                               (64,547)      (296,470)
     Principal payments on capital lease             (6,036)       (19,722)
     Collection of shareholder recievables                          2,000
     Proceeds from sale of preferred stock                           9,500
     Dividends paid to preferred shareholders      (170,000)
         Net Cash Used in Financing Activities     (218,083)       332,494

Net Decrease in Cash and Cash Equivalents          (152,645)       108,300

Cash and Cash Equivalents - Beginning of            243,859         21,666
Period

Cash and Cash Equivalents - End of Period      $     91,214        129,966
</TABLE>

<PAGE>

                                 SURGICARE, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

 Note 1 - Basis of Presentation

     In the opinion of the SurgiCare's management, the accompanying unaudited
condensed, consolidated financial statements include all adjustments consisting
of only normal recurring adjustments necessary for a fair presentation of
SurgiCare's financial position at March 31, 2001 and the results of operations
and cash flows for the three months ended March 31, 2001 and 2000, respectively.

         Although the Company believes that the disclosures in these financial
statements are adequate to make the information presented not misleading,
certain information normally included in financial statements prepared in
accordance with generally accepted accounting principles has been condensed or
omitted pursuant to the rules and regulations of the Securities and Exchange
Commission. Results of operations for the three months ending March 31, 2001 are
not necessarily indicative of results of operations to be expected for the year
ending December 31, 2001. Refer to the Company's financial statements on Form
10K-SB for the year ended December 31, 2000 for additional information.


Note 2- Accounting Policies

         SurgiCare, Inc. (the Company) maintains its accounts on the accrual
method of accounting in accordance with generally accepted accounting
principles. Accounting principles followed by the Company and the methods of
applying those principles which materially affect the determination of financial
position, results of operations and cash flows are summarized below:

   Principles of Consolidation

            These consolidated financial statements include the accounts of the
   Company and its wholly owned subsidiary, Bellaire SurgiCare, Inc. All
   material intercompany balances and transactions have been eliminated in
   consolidation.

   Cash and Cash Equivalents

            The Company considers all short-term investments with an original
   maturity of three months or less to be cash equivalents.

   Revenue Recognition

            Revenue is recognized on the date the procedures are performed, and
   accounts receivable are recorded at that time. Revenues are reported at the
   estimated realizable amounts from patients and third-party payers. Earnings
   are charged with a provision for contractual adjustments and doubtful
   accounts based on fee schedules, contracts and collection experience.
   Contractual adjustments and accounts deemed uncollectible are applied against
   the allowance account.

   Inventory

            Inventory consists of medical and pharmaceutical supplies which are
   stated at the lower of cost or market. Cost is determined under the first-in,
   first-out method.
<PAGE>

                                 SURGICARE, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

   Property and Equipment

            Property and equipment are presented at cost. Medical and surgical
   equipment, of approximately $287,044, under capital lease is recorded at the
   present value of future minimum lease payments. Depreciation and amortization
   are computed at rates considered sufficient to amortize the cost of the
   assets, using the straight-line method over their estimated useful lives as
   follows:


                  Office furniture and equipment     7   years
                  Medical and surgical equipment     5   years
                  Leasehold improvements             5   years
                  Computer equipment                 5   years

   Goodwill

            Goodwill arises from the acquisition of assets at an amount in
   excess of their fair market value. Amortization is computed by the
   straight-line method over 15 years.

   Federal Income Taxes

            Prior to July 1, 1999, the Company had elected to be taxed as an S
   corporation under provisions of the Internal Revenue Code. As such, current
   taxable income had been included on the income tax returns of the
   shareholders for federal income tax purposes and no provision had been made
   for federal income taxes.

            Effective July 1, 1999, the Company changed its election to be taxed
   as a C corporation under the Internal Revenue Code. Taxes on income are
   provided based upon Statement of Financial Accounting Standards No. 109,
   "Accounting for Income Taxes," which requires an asset and liability approach
   to financial accounting and reporting for income taxes. Deferred income tax
   assets and liabilities are computed for differences between the financial
   statement and tax bases of assets and liabilities that will result in taxable
   or deductible amounts in the future. Such deferred income tax asset and
   liability computations are based on enacted tax laws and rates applicable to
   periods in which the differences are expected to affect taxable income.

   Use of Estimates

            The preparation of financial statements in conformity with generally
   accepted accounting principles requires management to make estimates and
   assumptions that affect the reported amounts of assets and liabilities and
   disclosure of contingent assets and liabilities at the date of the financial
   statements and the reported amounts of revenues and expenses during the
   reporting period. Actual results could differ from those estimates.


<PAGE>

The following table sets forth the computation of basic and diluted earnings per
share:

<TABLE>
<CAPTION>

                                                                          For the Three
                                                                          Months Ended
                                                                           March 31,
                                                                          (Unaudited)
                                                                          -------------
                                                                      2000              2001

<S>                                                              <C>              <C>
Basic Earnings Per Share:
   Net earnings                                                 $      478,721      367,063
   Less: Preferred dividends                                           170,000
                                                                --------------    --------------
   Net earnings available for common shareholders
                                                                $      248,721      367,063
                                                                ==============    ===============
   Weighted average shares outstanding                              12,596,657   13,954,320
                                                                ==============    ===============
   Net earnings per share - basic                                         $.02        $.024
                                                                ==============    ===============


</TABLE>


Note 3 - Preferred Stock

         The Series A preferred stock is convertible at a rate of one share of
preferred stock into one share of $.005 par value common stock. The Company can
redeem the stock at $5 per share. The Series A preferred stock accrues dividends
at a rate of $.48 per share per annum which are payable, in arrears, on the
first day of the month. Holders of Series A preferred stock are entitled to one
vote for each share of Series A preferred stock held.


ITEM 2.

     Management's  Discussion and Analysis of Financial Condition and results of
Operation.  The information  contained  herein contains  certain forward looking
statements  within the meaning of Section 27A of the  Securities Act of 1933, as
amended and  Section 21E of the  Securities  Exchange  Act of 1934,  as amended,
which are intended to be covered by the safe harbors created thereby.  Investors
are cautioned that all forward looking statements involve risks and uncertainty,
including,  without  limitation,  the  ability  of  SurgiCare  to  continue  its
expansion strategy,  changes in federal or state healthcare laws and regulations
or third party payer practices,  SurgiCare's  historical and current  compliance
with existing or future  healthcare  laws and  regulations and third party payer
requirements, changes in costs of supplies, labor and employee benefits, as well
as general  market  conditions,  competition  and  pricing.  Although  SurgiCare
believes  that  the  assumptions   underlying  the  forward  looking  statements
contained herein are reasonable, any of the assumptions could be inaccurate, and
therefore,  there  can be no  assurance  that  the  forward  looking  statements
included  in  this  Form  10K-SB  will  prove  to be  accurate.  In  view of the
significant  uncertainties  inherent in the forward-looking  statements included
herein,  the  inclusion  of  such  information  should  not  be  regarded  as  a
representation by SurgiCare or any other person that the objectives and plans of
SurgiCare  will be achieved.  SurgiCare  undertakes  no  obligation to update or
revise forward-looking statements to reflect changed assumptions, the occurrence
of unanticipated events or changes to future operating results over time.

     SurgiCare's  principal  business  strategies  are to (i) increase  both the
revenue and  profits,  from  current  cases and  procedures  being  performed in
existing  facilities  and, (ii) achieve  growth and expand  revenues by pursuing
strategic  acquisitions of existing, and the development of new, physician owned
ambulatory surgical centers.


     (i)  SurgiCare is  constantly  working to achieve  increase  profits from
     existing  revenues.  Surgical  supply  costs are the  single  largest  cost
     component of any ambulatory surgical center.  Therefore SurgiCare is always
     looking  for  ways to  decrease  the  cost of  surgical  supplies.  Through
     participation  in  national  buying  groups  SurgiCare  has  been  able  to
     negotiate  discounts  on  most  of the  commonly  used  surgical  supplies.
     SurgiCare has also implemented a "Just in Time" approach to inventory. This
     allows the center to minimize the amount of supplies that it is required to
     keep in inventory. SurgiCare is also always looking for new distributors of
     its surgical  supplies that have the  capability to deliver the majority of
     its surgical  supplies  "Just in Time",  and provide  quality  service,  at
     reduced  prices.  SurgiCare  has found that the  purchasing  policies  that
     govern  the  acquisition  of  surgical  equipment  is an  important  key to
     maximize a centers  profit.  Therefore  all  equipment  is purchased at the
     corporate level, in order to insures that the equipment is purchased at the
     lowest possible price.

     (ii)  SurgiCare  is in the  process  of  identifying  ambulatory  surgical
     centers as potential acquisition targets, and has, in some cases, conducted
     preliminary  discussions with  representatives  of centers.  At the time of
     this filing there are no  commitments,  understandings,  or agreements with
     any  potential  acquisition  targets.  All of such  discussions  have  been
     tentative  in nature  and there can be no  assurance  that  SurgiCare  will
     acquire any center with whom  discussions  have been  conducted.  SurgiCare
     expects that generally the  acquisition of another surgery center will take
     the  form  of  a  merger,   stock-for-stock  exchange  or  stock-for-assets
     exchange,  and that in most  instances  the  target  company  will  wish to
     structure  the  business  combination  to be  within  the  definition  of a
     tax-free  reorganization  under Section 368 of the Internal Revenue Code of
     1986, as amended. SurgiCare may, however, use other acquisition structuring
     techniques,  including  purchases  of  assets or stock for cash or cash and
     stock, or through formation of one or more limited  partnerships or limited
     liability companies.


FINANCIAL CONDITION AND RESULTS OF OPERATION

     The following table sets forth for the periods indicated the percentages of
revenues represented by income statement items.


RESULTS OF OPERATION

The following table sets forth for the period indicated the number of surgical
cases.
<TABLE>
<CAPTION>

                                                              For the
                                                        Three Months Ended
                                                             March 31,
                                                       1999             2000

<S>                                                  <C>                <C>
Total Number of Cases                                 657              1,343

Total Revenues Generated                          $ 1,228,703      $  3,168,317

Revenue Generated per Case                        $   1,870        $     2,359

Earnings Before Federal Income Tax per Case       $    958         $       449

</TABLE>


THREE MONTHS ENDING MARCH 31, 2001 vs THREE MONTHS ENDING MARCH 31, 2000

     SurgiCare  is  continuing  to making a concerted  effort to  increase  both
revenues  and  profits.  One of the tools  that  SurgiCare  has used to  achieve
increased revenues and profits, is a program that involves constantly monitoring
the profitability of specific procedures,  and service. This information is then
used to decreasing the number of cases being done in those less profitable, high
cost  services,  and  increasing  the  number  of cases  being  done in the more
profitable less cost intensive  services.  Since the acquisition of the Memorial
Village Surgery Center, in October 2000,  SurgiCare has been evaluating the type
of procedures being performed at the center to determine the course of action in
order to increase the profitability per case.

     SurgiCare performed 1,343 case by March 31, 2001 compared to 657 procedures
done for the same  period in 2000,  this  represents  an over 100%  increase  in
average monthly  utilization This is due to the addition of the Memorial Village
Surgery Center.  The revenues  generated per case increased 25% from $1,870 for
the three month period ending March 31, 2000, to $2,359 for the same three month
period in 2001. The pre-tax earnings  generated per case decreased  53%from $958
per case for the three month period  ending March 31, 2000, to $449 for the same
three month  period in 2001.  This is in part due to the use of  specialty  pain
management  implants  increased in numbers for the Quarter ending March 31, 2001
creating the appearance of a lower  earnings per  procedure.  Third party payers
have a  fixed  reimbursement  for  implants  at our  cost  plus a  predetermined
percentage  multiplier  that in all cases is less than our usual profit  margin.
Earnings  per case  appear to drop  because  of this low profit cap and the high
cost of these implants.

     In  addition  the  procedure  mix at the newly  acquired  Memorial  Village
Surgery Center is in the process of being evaluated. SurgiCare has placed a high
degree of importance in maximizing profit and utilization through the monitoring
and control of specific specialties and procedure.

     In the three months ending March 31, 2001 SurgiCare recorded record revenue
of  $3,168,317  compared  to  $1,228,703  for the  same  period  in  2000,  this
represents  a 258%  increase.  This 258%  growth  in  revenues,  coupled  with a
significantly  slower  growth in  virtually  all cost as a  percentage  of total
revenue,  translated  to an increase in pre-tax  earning of 42% to $629,091 from
$440,556.

LIQUIDITY and CAPTIAL RESOURCES

         SurgiCare's current source of liquidity consists primarily of funds
from operations. SurgiCare believes that the cash available from operations is
adequate to meet the company's operational requirements.


PART II
                                OTHER INFORMATION
ITEM 1.
Legal Proceedings

         SurgiCare is not currently involved in any legal proceedings.

ITEM 2.
Change in Securities and Use of Proceeds

     On April  21,  2001 the  company  filed a form  15-12g,  de-registering  it
Preferred Series "A" securities.

ITEM 3.
Default Upon Senior Securities

         SurgiCare has not defaulted on any payments of principle or interest on
any securities.


ITEM 4.
Submission of Matters to a Vote of Security Holder

     None


                                   SIGNATURES



In accordance with the requirements of the Exchange Act, the Registrant caused
this Report to be signed on its behalf by the undersigned, thereunto duly
authorized.


Date:    May 21, 2001                               REGISTRANT:

                                                        SurgiCare, Inc.

                                                By: /s/ David Blumfield
                                                     Dr. David Blumfield
                                                     President and CEO


                                                By:  /s/ CHARLES S. COHEN
                                                     Charles S. Cohen
                                                     Chief Operating Officer


ITEM 6.
INDEX TO EXHIBITS

                                                           DESCRIPTION
     EXHIBIT
     NUMBER
       3.1         * Amended and Restated Certificate of Incorporation of
                     SurgiCare, Inc.
       3.2         * Articles of Incorporation of Bellaire SurgiCare, Inc.
       3.3         * By-Laws of Technical Coatings Incorporated
                     (now SurgiCare, Inc.)
       3.4         * By-Laws of Bellaire SurgiCare, Inc.
        4          * Certificate of Designation,  Powers, Preferences and Rights
                     of Series A Redeemable  Preferred  Stock, par value $.001
                     per share, of SurgiCare, Inc.
      10.1         * Agreement, dated July 29, 1989, 1999, between
                     SurgiCare, Inc. and Surgery Centers of
                                America II, Inc.
      10.2         * Letter agreement with SCOA
       27          * Financial Data Schedule


* Incorporated herein by reference to the Company's Current Report on form 10-SB
filed on August 20, 1999.

     During the three months ended March 31, 2001, SurgiCare filed the following
current  reports on 10K-SB  April 2, 2001 - Form 8-K March 7, 2001 - Form 15-12g
February  21,  2001 - Form 8-K  February  12,  2001- Form 4's January 18, 2001 -
8-K/A January 8, 2001 - 8-K January 3, 2001